Biochem/physiol Actions
Cell permeable: no
Reversible: no
Product does not compete with ATP.
Target IC50: 1.4 nM against ouabain-sensitive Na+,K+-ATPase activity
Primary TargetOuabain-sensitive Na+,K+-ATPase activity
General description
A cardiotonic steroid isolated from Bufo species toads that potently inhibits ouabain-sensitive Na+,K+-ATPase activity. Induces apoptosis in various human cell lines such as leukemia HL60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+-K+-ATPase inhibitors. Reduces the level of topoisomerase II in human leukemia cells.
A cardiotonic steroid isolated from toads of Bufo species that potently inhibits ouabain-sensitive Na+,K+-ATPase activity (IC50 = 1.4 nM). Induces apoptosis in various human cell lines such as leukemia HL-60 and U937 cells by altering the expression of apoptosis-related genes. Reported to stimulate the activities of p21 activated kinase (PAK) and c-Jun Kinase (JNK) in leukemic cell lines. Induces a transient increase in the expression of Tiam1 mRNA in U937 cell lines (~100 nM). Bufalin also down-regulates gene expression of the intracellular signaling protein 14-3-3 in rat lens, probably a consequence of Na+,K+-ATPase inhibition. Reduces the level of topoisomerase II in human leukemia cells.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Due to the nature of the Hazardous Materials in this shipment, additional shipping charges may be applied to your order. Certain sizes may be exempt from the additional hazardous materials shipping charges. Please contact your local sales office for more information regarding these charges.
Kurosawa, M., et al. 2000. Am. J. Physiol.278, C500.Kawazoe, N., et al. 1999. Oncogene 18, 2413.McGowan, M.H., et al. 1999. J. Pharmacol. Exp. Ther. 289, 1559.Watabe, M., et al. 1998. Oncogene 16, 779.Hashimoto, S., et al. 1997. Leuk. Res. 21, 875.Morris, J.F., et al. 1997. Comp. Biochem. Physiol. A Physiol. 118, 599.Brownlee, A.A., et al. 1990. Clin. Sci.78, 169.
Packaging
Packaged under inert gas
10 mg in Alu drum
Reconstitution
Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
Warning
Toxicity: Highly Toxic (H)
This product has met the following criteria to qualify for the following awards: